View Item 

Show simple item record

Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats

dc.contributor.authorWatson, Stanley J.en_US
dc.contributor.authorWoods, James H.en_US
dc.contributor.authorFolk, John E.en_US
dc.contributor.authorRice, Kenner C.en_US
dc.contributor.authorTorregrossa, Mary M.en_US
dc.date.accessioned2006-09-11T17:42:11Z
dc.date.available2006-09-11T17:42:11Z
dc.date.issued2005-11en_US
dc.identifier.citationTorregrossa, Mary M.; Folk, John E.; Rice, Kenner C.; Watson, Stanley J.; Woods, James H.; (2005). "Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats." Psychopharmacology 183(1): 31-40. <http://hdl.handle.net/2027.42/46371>en_US
dc.identifier.issn1432-2072en_US
dc.identifier.issn0033-3158en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46371
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16220339&dopt=citationen_US
dc.description.abstractSelective delta opioid receptor agonists have been shown to produce antidepressant-like behavioral effects and increase brain-derived neurotrophic factor (BDNF) mRNA expression when given acutely, but the chronic effects of delta agonists have been less well characterized.en_US
dc.format.extent364165 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherIn Situ Hybridizationen_US
dc.subject.otherAntidepressanten_US
dc.subject.otherBDNFen_US
dc.subject.other(+)BW373U86en_US
dc.subject.otherDelta Opioid Receptoren_US
dc.subject.otherForced Swim Testen_US
dc.titleChronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in ratsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumNeuroscience Program, University of Michigan, Ann Arbor, MI, USA, ; Department of Pharmacology, University of Michigan Medical School, 1301 MSRB III, Ann Arbor, MI, 48109-0632, USA,en_US
dc.contributor.affiliationumNeuroscience Program, University of Michigan, Ann Arbor, MI, USA,en_US
dc.contributor.affiliationumNeuroscience Program, University of Michigan, Ann Arbor, MI, USA, ; Mental Health Research Institute, University of Michigan, Ann Arbor, MI, USA,en_US
dc.contributor.affiliationotherNIDDK, NIH, DHHS, Bethesda, MD, USA,en_US
dc.contributor.affiliationotherNIDDK, NIH, DHHS, Bethesda, MD, USA,en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid16220339en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46371/1/213_2005_Article_113.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s00213-005-0113-5en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2005_Article_113.pdf
Size:
355.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.